Wedge Capital Management’s Utah Medical Products UTMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-6,684
| Closed | -$579K | – | 509 |
|
|
2021
Q1 | $579K | Buy |
6,684
+266
| +4% | +$23.4K | 0.01% | 356 |
|
|
2020
Q4 | $541K | Hold |
6,418
| – | – | 0.01% | 395 |
|
|
2020
Q3 | $513K | Hold |
6,418
| – | – | 0.01% | 370 |
|
|
2020
Q2 | $569K | Hold |
6,418
| – | – | 0.01% | 350 |
|
|
2020
Q1 | $604K | Sell |
6,418
-3,155
| -33% | -$293K | 0.01% | 329 |
|
|
2019
Q4 | $1.03M | Sell |
9,573
-5,755
| -38% | -$583K | 0.01% | 336 |
|
|
2019
Q3 | $1.47M | Hold |
15,328
| – | – | 0.02% | 291 |
|
|
2019
Q2 | $1.47M | Sell |
15,328
-3,199
| -17% | -$269K | 0.02% | 299 |
|
|
2019
Q1 | $1.64M | Buy |
18,527
+3,545
| +24% | +$312K | 0.02% | 309 |
|
|
2018
Q4 | $1.25M | Hold |
14,982
| – | – | 0.02% | 308 |
|
|
2018
Q3 | $1.41M | Hold |
14,982
| – | – | 0.01% | 319 |
|
|
2018
Q2 | $1.65M | Buy |
14,982
+10,582
| +241% | +$1.11M | 0.02% | 290 |
|
|
2018
Q1 | $435K | Sell |
4,400
-500
| -10% | -$44.6K | ﹤0.01% | 466 |
|
|
2017
Q4 | $399K | Hold |
4,900
| – | – | ﹤0.01% | 481 |
|
|
2017
Q3 | $360K | Hold |
4,900
| – | – | ﹤0.01% | 489 |
|
|
2017
Q2 | $355K | Hold |
4,900
| – | – | ﹤0.01% | 481 |
|
|
2017
Q1 | $305K | Hold |
4,900
| – | – | ﹤0.01% | 495 |
|
|
2016
Q4 | $356K | Hold |
4,900
| – | – | ﹤0.01% | 479 |
|
|
2016
Q3 | $293K | Hold |
4,900
| – | – | ﹤0.01% | 516 |
|
|
2016
Q2 | $309K | Hold |
4,900
| – | – | ﹤0.01% | 495 |
|
|
2016
Q1 | $306K | Sell |
4,900
-600
| -11% | -$35.4K | ﹤0.01% | 507 |
|
|
2015
Q4 | $322K | Hold |
5,500
| – | – | ﹤0.01% | 510 |
|
|
2015
Q3 | $296K | Sell |
5,500
-100
| -2% | -$5.45K | ﹤0.01% | 522 |
|
|
2015
Q2 | $334K | Hold |
5,600
| – | – | ﹤0.01% | 514 |
|
|
2015
Q1 | $335K | Hold |
5,600
| – | – | ﹤0.01% | 511 |
|
|
2014
Q4 | $336K | Sell |
5,600
-900
| -14% | -$49.8K | ﹤0.01% | 503 |
|
|
2014
Q3 | $317K | Buy |
6,500
+100
| +2% | +$5.08K | ﹤0.01% | 498 |
|
|
2014
Q2 | $329K | Buy |
6,400
+500
| +8% | +$25.7K | ﹤0.01% | 498 |
|
|
2014
Q1 | $341K | Hold |
5,900
| – | – | ﹤0.01% | 410 |
|
|
2013
Q4 | $337K | Buy |
5,900
+600
| +11% | +$32.9K | ﹤0.01% | 415 |
|
|
2013
Q3 | $315K | Buy |
5,300
+200
| +4% | +$10.9K | ﹤0.01% | 399 |
|
|
2013
Q2 | $277K | Buy |
+5,100
| New | +$240K | ﹤0.01% | 423 |
|
Other funds holding UTMD
RHJA
Wedge Capital Management's UTMD Position: Q2 2021 in Review
Wedge Capital Management sold out of Utah Medical Products (UTMD) in Q2 2021, closing a stake of 6,684 shares — an estimated $579K sold.
Wedge Capital Management first reported a position in UTMD in Q2 2013 and held it in 32 quarters. The position peaked at $1.65M in Q2 2018. 68 funds tracked by Wall St. Rank hold UTMD as of Q2 2021.
- Wedge Capital Management reported no remaining Utah Medical Products position as of Q2 2021 after selling out during the quarter.
- Wedge Capital Management sold 6,684 Utah Medical Products shares in Q2 2021, an estimated $579K.
- Wedge Capital Management first reported a position in Utah Medical Products in Q2 2013 and held it in 32 quarters.
- Wedge Capital Management's Utah Medical Products position peaked at $1.65M in Q2 2018.
- 68 funds tracked by Wall St. Rank held Utah Medical Products as of Q2 2021.
Based on Wedge Capital Management's 13F filing for Q2 2021, filed 14 Jul 2021.